NCT02070692View on ClinicalTrials.gov

Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users

PHASE4CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Menstruation Disturbances
Interventions
DRUG

Tamoxifen

7 day course of tamoxifen during an episode of irregular vaginal bleeding

DRUG

Placebo

7 day course of placebo during an episode of irregular vaginal bleeding

Trial Locations (1)

97239

Oregon Health & Science University (OHSU), Portland

All Listed Sponsors
collaborator

Society of Family Planning

OTHER

lead

Oregon Health and Science University

OTHER

NCT02070692 - Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users | Biotech Hunter | Biotech Hunter